EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

SPP1 (osteopontin): a key regulator orchestrating cancer progression and non-cancerous pathologies - therapeutic opportunities and future directions

Bo Pang, Huan Sun, Mingyu Ouyang, Cong Hu

Frontiers in Cell and Developmental Biology · 05.08.2026 · 14

DOI: 10.3389/fcell.2026.1912468 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 05.08.2026. Verfasst von Bo Pang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, First Hospital of Jilin University, Changchun, Jilin, China. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Secreted Phosphoprotein 1 (SPP1) is a multifaceted matricellular glycoprotein that mediates diverse biological processes via integrin and CD44 receptor signaling. While its profound contributions to tumor progression and metastasis are extensively documented, emerging evidence underscores its pivotal roles across diverse non-cancerous conditions, including pregnancy-related complications, fibrotic diseases and neurological disorders. Crucially, SPP1 exhibits functional pleiotropy, orchestrating angiogenesis and epithelial-mesenchymal transition, while modulating immunosuppression. These collective actions drive disease progression, establishing SPP1 as a compelling therapeutic target. This review synthesizes current understanding of SPP1 biology, highlighting mechanistic insights imperative for translating its therapeutic potential into safe, precision-targeted interventions against diverse SPP1-driven pathologies.

Schlagwörter

Stichwörter der Autor:innen

angiogenesisepithelial-mesenchymal transitionpregnancysecreted phosphoprotein 1tumor

Autor:innen und Institutionen

  • Cardiology Department, First Hospital of Jilin University, Changchun, Jilin, China.
  • Electrodiagnosis Department, Qianwei Hospital of Jilin Province, Changchun, China.
  • Department of Reproductive Medicine, Hezhou People's Hospital of Guangxi Zhuang Autonomous Region, Hezhou, China.
  • Reproductive Medicine Center, Prenatal Diagnosis Center, First Hospital of Jilin University, Changchun, Jilin, China.

Zitieren

APA

Pang, B., Sun, H., Ouyang, M., & Hu, C. (2026). SPP1 (osteopontin): a key regulator orchestrating cancer progression and non-cancerous pathologies - therapeutic opportunities and future directions. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1912468

Vancouver

Pang B, Sun H, Ouyang M, Hu C. SPP1 (osteopontin): a key regulator orchestrating cancer progression and non-cancerous pathologies - therapeutic opportunities and future directions. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1912468

BibTeX
@article{Pang2026,
  author = {Pang, Bo and Sun, Huan and Ouyang, Mingyu and Hu, Cong},
  title = {SPP1 (osteopontin): a key regulator orchestrating cancer progression and non-cancerous pathologies - therapeutic opportunities and future directions},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1912468}
}
Kostenlos starten →